Okupe Oluyemi 4
Research Summary
AI-generated summary
Hims & Hers (HIMS) CFO Okupe Oluyemi Receives 300,978 RSUs
What Happened
- Okupe Oluyemi, Chief Financial Officer of Hims & Hers Health, Inc. (HIMS), was granted 300,978 restricted stock units (RSUs) on 2026-03-11. The award was granted at $0.00 per unit (no cash exchanged) and is reported as a derivative award that can convert to ordinary shares upon vesting.
Key Details
- Transaction date: 2026-03-11; Form 4 filed: 2026-03-13 (reporting period 2026-03-11).
- Grant: 300,978 RSUs; price reported: $0.00; reported value: $0 (derivative award).
- Shares owned after transaction: Not disclosed in the filing.
- Footnote F1: Each RSU represents a contingent right to receive one share of Class A common stock upon vesting.
- Footnote F2: RSUs vest based on service over 4 years in substantially equal quarterly installments on Mar 15, Jun 15, Sep 15 and Dec 15, with the first vesting date on June 15, 2026.
- Transaction code: A (award/grant). Filing does not indicate lateness.
Context
- This is a compensation award, not an open-market purchase or sale — it does not reflect an immediate cash investment or liquidation by the insider. RSUs convert to actual shares only as they vest according to the schedule above. For retail investors, such grants indicate company compensation practice and potential future dilution as units vest and convert to shares.